Loading...
Noida 201301 (INDIA)
Mon - Sat : 09.00 AM - 09.00 PM
18001200365

Core Services

RLD Sourcing for BA/BE Studies & R&D in India

Protocol-Aligned Comparator Selection. Batch Consistency. Study-Ready Supply.

Ikris Pharma Network provides specialized RLD sourcing for BA/BE studies in India, supporting pharmaceutical companies, CROs, and research organizations with accurate, compliant, and study-aligned comparator sourcing for bioequivalence studies, formulation development, and early-stage R&D programs.

With over a decade of experience, we understand that in BA/BE studies, the accuracy of comparator selection directly determines study validity, regulatory acceptance, and approval timelines.
12+
Years in RLD & Comparator Sourcing
24h
Availability & Quote Turnaround
3+
Regulated Markets: US, EU, UK
GDP
EU-Certified Warehouse for Fast Access

Overview

What is RLD Sourcing for BA/BE Studies?

Understanding the role of Reference Listed Drugs in bioequivalence and R&D programs.

What is RLD Sourcing?

RLD sourcing for BA/BE studies involves procuring Reference Listed Drugs from regulated markets such as the US, EU, and UK for use as comparators in bioequivalence studies, ensuring regulatory compliance and accurate study outcomes.

Role of RLD in BA/BE Studies & R&D

In bioequivalence studies, the RLD serves as the reference product against which a generic formulation is compared. The selected comparator must align with:

  • FDA Orange Book (US reference product)
  • EMA-approved reference products (EU)
  • MHRA-approved comparators (UK)

Why It Matters

Why RLD Sourcing is Critical for BA/BE Studies

Based on real-world experience, these are the most common risks in BA/BE and formulation programs.

⚠️

Incorrect Reference Selection

Using a non-listed or incorrect comparator leads to regulatory non-acceptance.

🔬

Batch Variability

Different batches across study phases can affect bioequivalence outcomes.

🌐

Market Misalignment

US vs EU comparator mismatch can result in submission delays.

⏱️

Supply Delays

Late sourcing impacts study timelines and trial execution.

These issues can lead to repeat studies, increased costs, and delayed approvals.

What We Offer

Our RLD Sourcing Capabilities for BA/BE & R&D

Comprehensive sourcing solutions aligned with your study protocol, reference market, and regulatory requirements.

Comparator Sourcing for BA/BE Studies

  • FDA Orange Book-listed RLD sourcing
  • EMA and MHRA comparator alignment
  • Study-specific comparator identification

Support for Early-Stage R&D Programs

  • Sourcing for formulation development
  • Pilot batch procurement
  • Small-quantity supply for research use

Multi-Strength & Batch-Specific Sourcing

  • Multiple strengths for study requirements
  • Same batch procurement for consistency
  • Matching dosage forms and formulations

Fast-Track Supply for Urgent Studies

  • Accelerated sourcing timelines
  • Priority procurement from regulated markets
  • Rapid documentation and dispatch

Compliance

Regulatory & Documentation Support

Every RLD shipment is supported with complete study-ready documentation for smooth import clearance and BA/BE compliance.

Certificate of Analysis (CoA)
Batch Traceability & Pedigree Records
Commercial Invoice & Packing List
Regulatory Reference Documentation

Selection Guide

How to Choose the Right RLD for BA/BE Studies

A wrong comparator decision can invalidate your entire study. Selecting the correct comparator requires:

Regulatory AlignmentMatch RLD with target authority — USFDA, EMA, or MHRA
Reference Market SelectionChoose the correct market for the submission strategy
Batch ConsistencyEnsure the same batch is used across all study phases
Product IntegrityMaintain cold-chain and storage conditions throughout

Our Clients

Who We Support

Supporting global drug development programs and regulatory submissions.

💊
Pharmaceutical Companies

Generic manufacturers and innovator companies running regulatory submissions

🔬
CROs & Research Organizations

Clinical research organizations managing multi-site global BA/BE programs

⚗️
R&D & Formulation Teams

Teams working on formulation development and pilot batch programs

🏭
Generic Drug Development Companies

Companies preparing ANDA, NDDS, or BA/BE study dossiers


Logistics

Integrated Logistics & Cold Chain Support

Critical for maintaining comparator integrity throughout the study.

GDP-Compliant Cold Chain

  • GDP-compliant cold chain logistics
  • Real-time temperature monitoring

Packaging & Shipping

  • Validated packaging systems
  • Secure international shipping

How It Works

How RLD Sourcing for BA/BE Studies Works

A streamlined 5-step process from study requirement to secure site delivery.

1

Share Requirements

Molecule, strength, reference market, batch & quantity

2

Comparator Identification

Based on FDA Orange Book / EMA reference listing

3

Quote in 24h

Verified sourcing with batch details & pricing

4

Documentation

Study-ready compliance documents prepared

5

Secure Delivery

Temperature-controlled shipment to your site


Why Ikris

Why Choose Ikris Pharma Network for BA/BE RLD Sourcing

We don't just supply comparators — we help ensure successful study outcomes and regulatory approval.

12+ Years ExperienceRLD sourcing and BA/BE comparator procurement in India
Clinical Trial ExpertiseDeep knowledge of clinical supply and formulation support
Global Sourcing NetworkStrong procurement across regulated markets worldwide
Regulatory Know-HowDeep understanding of bioequivalence study requirements
EU GDP-Certified WarehouseFaster, compliant sourcing of EU-origin reference products
Risk MitigationProven experience handling batch mismatch, errors & delays

Get Accurate RLD Supply for Your BA/BE Study

Avoid costly delays and ensure correct comparator selection from the start. Get verified availability, pricing, and documentation within 24 hours.


FAQs

Frequently Asked Questions

It involves procuring reference-listed drugs from regulated markets for use as comparators in bioequivalence studies.
Incorrect comparator selection can lead to study failure, regulatory rejection, and delays in drug approval.
You can source RLD for BA/BE studies in India through specialized providers like Ikris Pharma Network. The company ensures compliant sourcing, documentation, and delivery.
COA, batch records, invoice, pedigree, packing list, and regulatory documentation.
Availability is typically confirmed within 24 hours; delivery timelines depend on sourcing location and logistics complexity.

Get in Touch with Our Team

Looking for a reliable partner for pharmaceutical exports from India or Reference Listed Drug (RLD) services? Ikris Pharma Network combines regulatory expertise, verified sourcing, and a precision-driven supply process to meet your requirements with confidence.

Submit your requirement today and receive a prompt response from our specialists.

Call Us Now: 18001200365

Mail Us Now

info@ikrispharmanetwork.in

Office Address

905, I-Thum Business Park, Plot No. A-40, Unit No. 5, Tower A, Sector-62, Noida – 201301 (India)